Immune Therapies Showing Promise On Coronavirus: Johns Hopkins

Immune Therapies Showing Promise on Coronavirus: Johns Hopkins

Bloomberg Television

Covid-19 Showing Long-Term Health Impact: Johns Hopkins

Bloomberg Television

Lessons Learned from COVID-19 and What’s Next

Johns Hopkins Medicine

Covid-19 Immunity Shows Positive Signs, But Not Proven: Johns Hopkins

Bloomberg Television

Johns Hopkins Coronavirus Resource Center 30-Minute COVID-19 Briefing - Feb. 5, 2021

Johns Hopkins University

COVID-19 Update with Dr. Auwaerter of Johns Hopkins : Omicron Variant, Testing, and Treatment

Unbound Medicine

Covid Treatments Show ‘Good News All Around’: Johns Hopkins

Bloomberg Television

Pfizer, Moderna Vaccines Show Promise for mRNA: Johns Hopkins

Bloomberg Television

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - July 23, 2021

Johns Hopkins University

Covid-19: Johns Hopkins Sees ‘Great Hope’ in Antibodies Research

Bloomberg Television

COVID-19 Update with Dr. Paul Auwaerter of Johns Hopkins : Treatment and Vaccines

Unbound Medicine

Coronavirus Reinfection Is ‘Unlikely,’ Johns Hopkins’ Sharfstein Says

Bloomberg Television

Covid Becoming More Like Seasonal Flu: Johns Hopkins

Bloomberg Television

The Johns Hopkins 30-Minute COVID-19 Briefing: Dec. 11, 2020

Johns Hopkins University

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - June 25, 2021

Johns Hopkins University

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - Sept. 10, 2021

Johns Hopkins University

Covid-19 Wave Shows Increasing Mortality: Johns Hopkins’ Farley

Bloomberg Television

Johns Hopkins Coronavirus Resource Center Live 30-Minute Briefing - Feb. 11, 2022

Johns Hopkins University

Loosening Covid-19 Restrictions Shows Mixed Results: Johns Hopkins

Bloomberg Television

No Holy Grail for Covid-19 Treatments: Johns Hopkins

Bloomberg Television